https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/vivo-bio-tech-ltd.png Logo

Vivo Bio Tech Ltd Financial Statement

Vivo Bio Tech Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue11.5612.749.04
Operating Expense6.226.334.27
Net Profit0.71.320.25
Net Profit Margin6.0610.362.77
Earning Per Share0.470.890.16
EBIDTA5.386.424.82
Effective Tax Rate13.679.363.77

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Vivo Bio Tech Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual52.2351.3951.78
Operating Expenses Annual30.7335.5834.11
Operating Profit Annual21.5415.9117.74
Interest Annual7.653.993.53
Depreciation9.277.455.59
Net Profit Annual2.652.25.68
Tax Annual1.972.272.94

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Vivo Bio Tech Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning1.711.171.03
Cash Flow from Operations14.8316.6414.18
Cash Flow from Investing-4-51.11-22.82
Cash Flow from Financing-11.1835.028.78
Cash Flow at the End1.371.711.17

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Vivo Bio Tech Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)41.8931.534.53
PBIT Margin (%)24.1417.0123.74
PBT Margin (%)21.0813.0217.27
Net PROFIT Margin (%)5.094.2810.97
Return On Networth / Equity (%)5.354.9115.03
Return On Networth /Employed(%)10.979.2518.65
Return On Assets (%)2.292.318.67
Total Debt / Equity(X)1.271.050.67
Asset Turnover Ratio (%)0.450.540.79

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Vivo Bio Tech Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual88.8795.1752.05
Total Current Assets Annual31.7926.0327.09
Non Current Assets Annual91.2496.4552.44
Total Shareholders Funds Annual51.8747.1342.53
Total Assets Annual123.03122.4979.52

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Vivo Bio Tech Ltd Earning Calls
Mar 2024
EPS beaten by 0.00 %

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of June 22, 2024, Vivo Bio Tech Ltd has a market capitalization of 63.89 Cr. Value Research classifies it as a Micro-Cap company.

No, Vivo Bio Tech Ltd is not debt-free with a debt-to-equity ratio of 1.34.

In FY 2023, Vivo Bio Tech Ltd recorded a total revenue of approximately 45.45 Cr marking a significant milestone in the company's financial performance.

Vivo Bio Tech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and -0.1% annually, respectively..

Vivo Bio Tech Ltd's current PE ratio is 25.25.

Vivo Bio Tech Ltd's ROCE averaged 9.2% from the FY ending March 2022 to 2024, with a median of 9.3%. It peaked at 10.7% in March 2023, reflecting strong capital efficiency over the period..

Vivo Bio Tech Ltd's latest EBIT is Rs. 11.84 Cr, surpassing the average EBIT of Rs. 10.86 Cr over the 5 years..